Murali Doraiswamy

Murali Doraiswamy is an Indian physician-scientist, psychiatrist, and professor at Duke University School of Medicine.^[1] He is a leading expert in the fields of neurocognitive disorders, brain aging, and precision medicine.^[2] Doraiswamy is widely recognized for his research on Alzheimer's disease, psychiatric disorders, and the applications of artificial intelligence in mental health care.^[1] He has authored over 400 publications and co-authored the book The Alzheimer's Action Plan.^[3]

P. Murali Doraiswamy
Nationality	Indian
Alma mater	University of Madras
Known for	Neurocognitive disorders, artificial intelligence in psychiatry, Alzheimer's research
Notable work	The Alzheimer's Action Plan
Awards	Fellow of the Royal College of Physicians (London), Fellow of the American Neurological Association
Scientific career
Fields	Psychiatry, neuroscience, precision medicine
Institutions	Duke University School of Medicine

Early life and education

Doraiswamy earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Madras, India. After completing his medical education, he pursued residency training in psychiatry before joining Duke University, where he has built a distinguished career in neuroscience and clinical research.

Career

Doraiswamy serves as a professor in the Departments of Psychiatry and Medicine at Duke University School of Medicine. He is also the director of the Neurocognitive Disorders Program and holds affiliations with the Duke Center for Applied Genomics and Precision Medicine, the Duke Institute for Brain Sciences, and the Duke Initiative for Science & Society.^[4]

Research and publications

His research centers on neurocognitive disorders, Brain health, and the role of artificial intelligence in psychiatry. At Duke University, he leads a clinical trials unit that has contributed to the development of diagnostic tests, digital biomarkers, and treatments for neurodegenerative conditions. His work has had a major impact on Alzheimer's disease research, depression, and cognitive resilience in aging.^[1]

Doraiswamy has also served as an advisor to major institutions, including the National Institutes of Health (NIH),^[5] the Food and Drug Administration (FDA),^[6] the World Health Organization (WHO), and the World Economic Forum (WEF).^[7] He has chaired global panels on Brain research and innovation in mental health care.^[8]

Selected works

• The Alzheimer's Action Plan (co-authored, 2008) – A comprehensive guide for patients and caregivers dealing with Alzheimer's disease.^[3]
• "Artificial Intelligence and the Future of Psychiatry: Insights from a Global Physician Survey" (2019) – A study on the integration of Artificial intelligence in mental health care.^[9]
• "Neuroimaging Assessment of Early and Late Neurobiological Sequelae of Traumatic brain injury" (2015) – Research on brain injury and its potential link to Chronic traumatic encephalopathy (CTE).^[10]
• Multiple peer-reviewed articles on cognitive disorders, Neuroplasticity, and Digital health interventions.

Public engagement and media

Doraiswamy's research has been featured in major media outlets, including The New York Times, TIME Magazine,^[11] Scientific American,^[12] The Wall Street Journal,^[13] and BBC News.^[14] He has appeared on television programs such as CBS Evening News,^[15] NPR,^[16] and The Dr. Oz Show. He was also featured in the documentaries (Dis)Honesty: The Truth about Lies^[17] and Mysteries of the Brain.^[18]

Awards and honors

• Recipient of multiple research awards for contributions to Psychiatry and neurodegenerative research^[19]

See also

• Neurocognitive disorders
• Alzheimer's disease research
• Psychiatry
• Artificial intelligence in medicine